百洋医药 (301015)

Qingdao Baheal Medical INC.

ASZ

Tags

Pharmaceutical CommerceContains Convertible BondsGuozheng Growth IndexSmall Cap GrowthDecreasing Shareholder CountIntelligent MachinesNew Private Equity HoldingsPrivate Equity Heavy PositionsHigh-Performing StocksCross-Border E-commerceHigh-Dividend StocksChiNext 200 IndexChiNext HealthcarePharma & BiotechStable Growth IndexAdvantageous Growth IndexSZSE Medicine Equal Weight IndexShenzhen A-Share Pharmaceutical IndexChiNext Composite IndexCSI All-share Pharmaceutical Sector IndexSZSE 700 IndexSSE 700 Growth IndexZhongchuang Growth IndexSZSE 1000 IndexCSSW Health IndexCSI 1000 Growth IndexSZSE Component Index ReturnCNI 1000 IndexCSSW Silk Road IndexExcellent Performance Strategy IndexSZSE Performance IndexZhongchuang Value IndexConvertible Bond IssuersJune 2022 Lock-up ExpiryInsurance Heavy HoldingsWholesale & Retail IndexSmall-cap High Beta IndexSZSE Responsibility IndexCNI Responsibility IndexSME Board Innovation IndexSZSE Pharmaceutical IndexCS Pharmaceutical TI IndexCSI 1000 IndexCNI Pharmaceutical IndexCSI 1000 Pharmaceutical IndexJuchao Small-cap IndexChiNext Basic IndexChina United Quality Growth IndexSZSE Component Pharmaceutical IndexCSI All-share Pharmaceutical IndexChiNext Low Volatility IndexSZSE Component Index Equal WeightPharmaceutical & Health 100 IndexMid-small Cap IndexPharmaceutical 50 IndexZhongchuang High Beta IndexCICC 300 IndexZhongchuang 400 IndexCSI 1000 Value IndexCSI 1000 Value Stable IndexPerformance IndexShandong

K-Line Chart

No K-line data available

Company NameQingdao Baiyang Pharmaceutical Co., Ltd.
Listing Date2021-06-30
Issue Price7.64RMB
Registered Capital52561.939810k RMB
Legal RepresentativeFu Gang
Registered AddressBuilding 1, No. 88 Tongbai Road, Shibei District, Qingdao City, Shandong Province
IndustryPharmaceutical Commerce
Main BusinessThe main business is to provide integrated marketing services for pharmaceutical product manufacturers.
Company ProfileQingdao Baiyang Pharmaceutical Co., Ltd. is the flagship enterprise of the Baiyang Pharmaceutical Group. Since its establishment in 2005, with brand operation as its core and logistics distribution as its support, it has conducted business cooperation with over 12,000 hospitals and more than 300,000 pharmacies. The business model of Qingdao Baiyang Pharmaceutical Co., Ltd. is divided into two major systems: brand operation and channel services. Currently, it has brand-oriented business divisions such as the Major Brand Division and the Medical Nutrition Division, having built several billion-yuan and hundred-million-yuan brands including D-Cal and Mite. Meanwhile, the company has channel service-oriented business divisions such as the Distribution Division and the KA Retail Division, providing upstream enterprises with omni-channel integrated solutions through innovative and efficient online and offline wholesale, retail, and cross-border e-commerce service systems. Gathering numerous streams to form a vast ocean. Through over a decade of effort, Qingdao Baiyang Pharmaceutical Co., Ltd. has evolved from a product-oriented enterprise into a platform-oriented enterprise and is now providing better health products and services to society with an open, inclusive, cooperative, and innovative approach.

Stock Details

1. Key Indicators

  • Total Shares(W): 52562.41
  • Circulating A-Shares(W): 52555.66
  • Earnings Per Share(RMB): 0.9100
  • Net Assets Per Share(RMB): 4.5314
  • Operating Revenue(W RMB): 562710.52
  • Total Profit(W RMB): 69528.87
  • Net Profit Attributable to Parent(W RMB): 47642.90
  • Net Profit Growth Rate(%): -25.67
  • Weighted Return on Equity(%): 20.2500
  • Operating Cash Flow Per Share(RMB): 1.1820
  • Undistributed Profit Per Share(RMB): 3.0901
  • Capital Reserve Per Share(RMB): 0.0555

2. Main Business

The main business covers:

  • Brand operation business
  • Wholesale and distribution business
  • Retail business

3. Company Basic Information

  • Company Name: Qingdao Baheal Medical INC.
  • Listing Date: 2021-06-30
  • Industry: Wholesale Trade
  • Address: No. 88 Kaifeng Road, Shibei District, Qingdao City, Shandong Province
  • Website: www.baheal.cn
  • Company Profile: The company was formerly known as Baheal Co., Ltd., established on March 8, 2005. In July 2016, Baheal Co., Ltd. was restructured into Baheal Pharmaceutical based on its audited net assets. The company is primarily engaged in brand operation, wholesale distribution, and retail business.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Baheal Medical Group Co., Ltd. General Legal Person 35729.86 67.98
2 Beijing Baheal Chengchuang Pharmaceutical Investment Co., Ltd. General Legal Person 2000.00 3.81
3 Taizhou Woyuan Private Fund Management Co., Ltd. - Woyuan Linsheng No.1 Private Securities Investment Fund Private Securities Investment Fund 1167.28 2.22
4 Tianjin Huitong Asset Management Partnership (Limited Partnership) General Legal Person 573.08 1.09
5 Taizhou Woyuan Private Fund Management Co., Ltd. - Woyuan Ruize No.1 Private Securities Investment Fund Private Securities Investment Fund 483.82 0.92
6 Tianjin Haohui Asset Management Partnership (Limited Partnership) General Legal Person 434.25 0.83
7 Tianjin Huizhong Asset Management Partnership (Limited Partnership) General Legal Person 430.43 0.82
8 Tianjin Qingzheng Asset Management Partnership (Limited Partnership) General Legal Person 373.50 0.71
9 Tianjin Huitong Asset Management Partnership (Limited Partnership) General Legal Person 327.01 0.62
10 Hong Kong Securities Clearing Company Ltd. Northbound Capital 290.97 0.55

5. Concept Sectors

  • Convertible Bonds
  • New Retail
  • Intelligent Machines
  • Cross-border E-commerce
  • Innovative Drugs
  • Margin Trading
  • High-performing Stocks
  • Decreasing Shareholder Numbers
  • High-dividend Stocks
  • New Private Placement
  • Private Placement Heavy Holdings
  • ChiNext 300
  • ChiNext Pharmaceuticals
  • ChiNext 200

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information